Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw as Exclusive Placement Agent for a $5 Million Registered Direct Offering
Press Release – New York, NY – August 26, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright& Co., LLC, as the exclusive placement agent for a registered direct offering of CEL-SCI Corporation (NYSE MKT: CVM), a pharmaceutical company that is focused on finding the best way to activate a patient’s immune response to fight cancer and infectious diseases (“CEL-SCI”).
CEL-SCI sold an aggregate of 10 million shares of common stock at a price of $0.50 per share and warrants to purchase 5 million shares of common stock at an exercise price of $0.55 per share.
The securities described above were offered and sold by CEL-SCI pursuant to an effective shelf registration statement on Form S-3.
The Sichenzia Ross Friedman Ference LLP team was led by Gregory Sichenzia, Stephen Cohen and Jay Yamamoto.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Medical Marijuana Dispensary Business Project 1493, LLC Announces Share Exchange Agreement with Public Entity & Simultaneous $3.3 Million PIPE Financing - June 16, 2017
- Sichenzia Ross Ference Kesner LLP Represents Immuron Limited on $6.1M IPO and NASDAQ listing - June 15, 2017
- Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, and Fordham Financial Management in $6.6 Registered Direct offering of Ampio Pharmaceuticals, Inc. - June 8, 2017